• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.91% Nasdaq Down 0.55%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.69 Down 0.03(1.10%) 1:49PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.72
    Open:2.76
    Bid:2.68 x 2200
    Ask:2.69 x 700
    1y Target Est:8.50
    Beta:3.46
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:2.66 - 2.84
    52wk Range:2.08 - 5.42
    Volume:778,677
    Avg Vol (3m):1,014,210
    Market Cap:174.91M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 1.10%174.91M
    LLYDown 0.80%88.78B
    NVSUp 0.16%250.98B
    SNYDown 0.76%140.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,515.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback